GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mercury Biopharmaceutical Corp (ROCO:6932) » Definitions » 5-Year Yield-on-Cost %

Mercury Biopharmaceutical (ROCO:6932) 5-Year Yield-on-Cost % : 0.00 (As of May. 01, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Mercury Biopharmaceutical 5-Year Yield-on-Cost %?

Mercury Biopharmaceutical's yield on cost for the quarter that ended in Dec. 2024 was 0.00.


The historical rank and industry rank for Mercury Biopharmaceutical's 5-Year Yield-on-Cost % or its related term are showing as below:



ROCO:6932's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.31
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Mercury Biopharmaceutical's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Mercury Biopharmaceutical's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mercury Biopharmaceutical's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mercury Biopharmaceutical's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Mercury Biopharmaceutical's 5-Year Yield-on-Cost % falls into.


;
;

Mercury Biopharmaceutical 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Mercury Biopharmaceutical is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Mercury Biopharmaceutical  (ROCO:6932) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Mercury Biopharmaceutical 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Mercury Biopharmaceutical's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mercury Biopharmaceutical Business Description

Traded in Other Exchanges
N/A
Address
No. 653-1, Bannan Road, 15th Floor, Zhonghe District, New Taipei City, TWN
Mercury Biopharmaceutical Corp focuses on the development of drugs for unmet medical needs. It offers a development platform focusing on rapid release and free adjustable doses. Its 3D powder bonding method (binder jetting) combines powder and special molding adhesive and stacks them in layers.

Mercury Biopharmaceutical Headlines

No Headlines